James Loerop Anika Therapeutics, Inc. (ANIK) insider trading activity

ANIK Quotes by TradingView

James Loerop is EVP Business Development of Anika Therapeutics, Inc.. Currently has a direct ownership of 5,592 shares of ANIK, which is worth approximately $95,679. The most recent transaction as insider was on Jul 08, 2021, when has been sold 731 shares (Common Stock) at a price of $43.24 per share, resulting in proceeds of $31,608. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.59K
0% 3M change
0% 12M change
Total Value Held $95,679

James Loerop Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 08 2021
SELL
Payment of exercise price or tax liability
$31,608 $43.24 p/Share
731 Reduced 11.56%
5,592 Common Stock
Jul 08 2021
BUY
Exercise of conversion of derivative security
-
3,000 Added 32.18%
6,323 Common Stock
Feb 25 2021
BUY
Exercise of conversion of derivative security
-
1,567 Added 32.04%
3,323 Common Stock

Also insider at

ACRS
Aclaris Therapeutics, Inc. Healthcare
Chief Business Officer
JL

James Loerop

EVP Business Development
Wayne, PA

Track Institutional and Insider Activities on ANIK

Follow Anika Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ANIK shares.

Notify only if

Insider Trading

Get notified when an Anika Therapeutics, Inc. insider buys or sells ANIK shares.

Notify only if

News

Receive news related to Anika Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ANIK